Luca Favero

Dr. Luca Favero


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
BRBernhard Reimers
Bernhard Reimers
HSHorst Sievert
Horst Sievert
GSGerhard C. Schuler
Gerhard C. Schuler
TTThilo Tübler
Thilo Tübler
KDKlaus Diederich
Klaus Diederich
GBGiancarlo Biamino
Giancarlo Biamino
Purpose: To evaluate the feasibility of cerebral protection during carotid artery stenting (CAS) using the Mo.Ma device, which prevents cerebral embolization by...

1 November 2020 in JACC
Verified
Journal Article
Closed access
GTGiuseppe Tarantini
Giuseppe Tarantini
MMMarco Mojoli
Marco Mojoli
FVFerdinando Varbella
Ferdinando Varbella
RCRoberto Caporale
Roberto Caporale
SRStefano Rigattieri
Stefano Rigattieri
GMGiuseppe Musumeci
Giuseppe Musumeci

1 June 2004 in Heart
Verified
Journal Article
Open access
PDF file
LVL La Vecchia
L La Vecchia
FOF Ottani
F Ottani
Luca FaveroLuca Favero
Luca Favero
GSG L Spadaro
G L Spadaro
ARA Rubboli
A Rubboli
AJAllan Jaffe
Allan Jaffe
Background: To investigate the frequency of cardiac troponin I (cTnI) increases in patients with pulmonary embolism (PE) and to assess the correlation between this finding, the clinical presentation, and outcomes. Methods: Consecutive patients admitted to the coronary care unit with acute PE were prospectively enrolled between January 2000 and December 2001. cTnI was sequentially determined. Various cut off concentrations were analysed, but patients were categorised prospectively as having increased or no increased cTnI based on a cut off concentration of 0.6 ng/ml. The main outcome measure was in-hospital mortality. Results: On admission, 14 of the 48 patients (29%) had cTnI concentrations greater than the receiver operating characteristic curve value used to diagnose acute myocardial infarction (> 0.6 ng/ml). Subsequently, six patients developed increases for an overall prevalence of 42% (20 of 42). The prevalence was higher when lower cut off concentrations were used: 73% (35 of 48) at the 99th centile and 60% (29 of 48) at the 10% coefficient of variability. Increased cTnI > 0.6 ng/ml was associated with a slower oxygen saturation (86 (7)% v 93 (4)%, p < 0.0001) and more frequent involvement of the main pulmonary arteries as assessed by spiral computed tomography (100% v 60%, p = 0.022). In-hospital mortality was 36% (5 of 14) of patients with increases > 0.6 ng/ml v 3% (1 of 42) of patients with lower concentrations (p = 0.008). Increased cTnI > 0.6 ng/ml on admission was the most powerful predictor of mortality (p = 0.046). Conclusions: In high risk patients with acute PE, cTnI was frequently detected on admission. It was the strongest independent predictor of mortality.

1 May 2011 in EuroIntervention
Verified
Journal Article
Closed access
BRBernhard Reimers
Bernhard Reimers
DNDimitrios Nikas
Dimitrios Nikas
ESEugenio Stabile
Eugenio Stabile
Luca FaveroLuca Favero
Luca Favero
SSSalvatore Saccà
Salvatore Saccà
PRPaolo Rubino
Paolo Rubino
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

14 May 2024 in JACC: Cardiovascular Interventions
Verified
Journal Article
Open access
AZAndrea Zito
Andrea Zito
ABAndrea Buono
Andrea Buono
Andrea ScottiAndrea Scotti
Andrea Scotti
WKWon-Keun Kim
Won-Keun Kim
TFTommaso Fabris
Tommaso Fabris
FBFrancesco Bianchini
Francesco Bianchini
Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BAV) stenosis is technically challenging and is burdened by an increased risk of paravalvular regurgitation (PVR). To identify the incidence, predictors, and clinical outcomes of PVR following TAVR in Sievers type 1 BAV stenosis. Consecutive patients with severe Sievers type 1 BAV stenosis undergoing TAVR with current generation transcatheter heart valves (THVs) in 24 international centres were enrolled. PVR was graded as none/trace, mild, moderate, and severe according to echocardiographic criteria. The endpoint of major adverse events (MAE), defined as a composite of all-cause death, stroke, or hospitalization for heart failure, was assessed at the last available follow-up. A total of 946 patients were enrolled. PVR occurred in 423 patients (44.7%): mild, moderate, and severe in 387 (40.9%), 32 (3.4%), and 4 (0.4%) patients, respectively. Independent predictors of moderate or severe PVR were larger virtual raphe ring (VRR) perimeter (ORadj 1.07, 95% CI 1.02-1.13), severe annular or left ventricular outflow tract (LVOT) calcification (ORadj 5.21, 95% CI 1.45-18.77), self-expanding valve (ORadj 9.01, 95% CI 2.09-38.86), and intentional supra-annular THV positioning (ORadj 3.31, 95% CI 1.04-10.54). At a median follow-up of 1.3 [IQR 0.5-2.4] years, moderate or severe PVR was associated with an increased risk of MAE (HRadj 2.52, 95% CI 1.24-5.09). After TAVR with current-generation THVs in Sievers type 1 BAV stenosis, moderate or severe PVR occurred in about 4% of cases and was associated with an increased risk of MAE during follow-up.

1 August 2006 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
BRBernhard Reimers
Bernhard Reimers
TTThilo Tübler
Thilo Tübler
GDGiammarco de Donato
Giammarco de Donato
MBMila Della Barbera
Mila Della Barbera
CCCarlo Cernetti
Carlo Cernetti
AAAnnalisa Angelini
Annalisa Angelini
Purpose: To evaluate the immediate and midterm outcome and analyze the debris captured after repeat endovascular intervention for the treatment of in-stent restenosis after carotid artery stenting (CAS). Methods: Thirty-one consecutive patients (27 men; mean age 63.7±13.0 years, range 53–81) underwent repeat endovascular intervention (balloon angioplasty and provisional stenting) for the treatment of 32 in-stent restenoses following CAS. Results: Procedural success was achieved in all patients. An additional stent was implanted in 10 (31%) cases. No procedural complication was observed. Filter analysis was performed in 17 (53%) procedures; on 12 (71%), macroscopically visible material was captured. The histomorphometric analysis performed on 6 (19%) filters showed fibrin nets entrapping erythrocytes, leucocytes, platelets, and in 2 cases, fibrous hypercellular tissue fragments. At 30 days and during follow-up (mean 17±5 months), no deaths, transient ischemic attacks, or strokes were observed. In 1 (3.1%) patient, asymptomatic recurrence of ISR was found on Doppler ultrasonography and successfully treated with balloon angioplasty. Conclusion: Repeat endovascular intervention using balloon angioplasty with provisional stenting and routine cerebral protection appears to be a feasible, safe, and clinically effective strategy for the treatment of in-stent restenosis after CAS.